Yuji Ogawa

Yokohama, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 98 publications

Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes.

Global Longitudinal Assessment of MASLD Using Magnetic Resonance Elastography (GOLDMINE): A Multi-Center, International Prospective Cohort Study of Imaging Biomarkers in MASLD Clinical Outcomes.

Journal: Alimentary pharmacology & therapeutics

Published: February 02, 2026

Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocol.

Pemafibrate for treating MASLD complicated by hypertriglyceridaemia: a multicentre, open-label, randomised controlled trial study protocol.

Journal: BMJ open

Published: November 24, 2024

Quantitative color analysis of the diets of patients with metabolic dysfunction-associated steatotic liver disease: Comparative study with nutritionally balanced diets.

Quantitative color analysis of the diets of patients with metabolic dysfunction-associated steatotic liver disease: Comparative study with nutritionally balanced diets.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: June 22, 2024

Distribution of Fibrosis-4 index and vibration-controlled transient elastography-derived liver stiffness measurement for patients with metabolic dysfunction-associated steatotic liver disease in health check-up.

Distribution of Fibrosis-4 index and vibration-controlled transient elastography-derived liver stiffness measurement for patients with metabolic dysfunction-associated steatotic liver disease in health check-up.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: May 16, 2024

Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASH.

Head-to-head comparison among FAST, MAST, and multiparametric MRI-based new score in diagnosing at-risk MASH.

Journal: European radiology

Published: May 13, 2024

Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib.

Assessing the economics of biologic and small molecule therapies for the treatment of moderate to severe ulcerative colitis in Japan: a cost per responder analysis of upadacitinib.

Journal: Journal of medical economics

Published: March 21, 2024

Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography.

Prediction of outcomes in patients with metabolic dysfunction-associated steatotic liver disease based on initial measurements and subsequent changes in magnetic resonance elastography.

Journal: Journal of gastroenterology

Published: July 01, 2023

Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease.

Combined, elobixibat, and colestyramine reduced cholesterol toxicity in a mouse model of metabolic dysfunction-associated steatotic liver disease.

Journal: Hepatology communications

Published: March 22, 2023

Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review.

Involvement of Periodontal Disease in the Pathogenesis and Exacerbation of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis: A Review.

Journal: Nutrients

Published: February 05, 2023

M-PAST score is better than MAST score for the diagnosis of active fibrotic nonalcoholic steatohepatitis.

M-PAST score is better than MAST score for the diagnosis of active fibrotic nonalcoholic steatohepatitis.

Journal: Hepatology research : the official journal of the Japan Society of Hepatology

Published: January 09, 2023

Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma.

Identification of differentially methylated regions associated with both liver fibrosis and hepatocellular carcinoma.

Journal: BMC gastroenterology

Published: December 02, 2022

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future.

Non-invasive imaging biomarkers for liver steatosis in non-alcoholic fatty liver disease: present and future.

Journal: Clinical and molecular hepatology

Published: October 31, 2022

Showing 1-12 of 98

Last Updated: 09/26/2026